Walking Won't Make You Young. Ozempic Won't Either. Here's What Actually Works After 50.

A customer walked into my shop last month. He was sixty-one, a retired schoolteacher, and he had lost fourteen kilograms in four months on Wegovy. He looked great in his clothes. He also looked tired in a way I recognized — the way men look right before their body sends them an invoice they did not expect.

He asked me what supplement he should take to "support" the medication.

I asked him a question instead. "How much of the fourteen kilograms was fat?"

He paused. He did not know. His doctor had probably said something about it, but it had been wrapped in medical language and surrounded by congratulations, so it had not registered. He had a number on the scale that was lower than it had been in twenty years, and he had stopped asking what kind of number it was.

That is the documented truth that nobody puts in an Ozempic commercial. And then, because I have been doing this for four years now and I am tired of watching men our age make the same mistake, I told him what actually works.

I told him the truth. The honest, well-styled truth.

I am not anti-medication. I am not pro-suffering. I am a fifty-nine-year-old former professional baseball player who became a corporate executive and now runs a health supplement shop — which means I have watched too many men trade their long-term bodies for short-term wins. I have done it myself. I have the medical bills, the failed supplements, and the four years of slow recovery to show for it.

So this is not opinion. It is what the research has been quietly saying since 2024, while the marketing has been loudly saying something else.

What I am about to tell you about GLP-1 medications and walking is not opinion. It is what the research has been quietly saying since 2024, while the marketing has been loudly saying something else.

The injection promises speed. The shoes promise something the injection cannot — durability.

What the Scale Doesn't Tell You

Here is the part the commercials skip.

When you lose weight rapidly on a GLP-1 drug — Ozempic, Wegovy, Mounjaro, the whole class — you do not just lose fat. You lose muscle too. And not a small amount.

The 2024 research published in journals like The Lancet Diabetes & Endocrinology and reviewed by clinicians at Mayo Clinic and Cleveland Clinic has been consistent: somewhere between 25 and 40 percent of the weight people lose on these medications is lean mass. That means muscle. That means bone density support. That means the tissue that keeps a sixty-year-old man from falling in his own kitchen at seventy-five.

For a younger person with a lot of fat to lose, this is a manageable trade. They have muscle to spare. They have decades to rebuild.

For a man over fifty, this math gets ugly fast.

We are already losing muscle every year after forty — somewhere between 0.5 and 1 percent annually if we do nothing about it. The medical term is sarcopenia, and it is not a cosmetic problem. It is the single biggest predictor of whether you will be independent at eighty or in a care facility.

So when a man my age loses fourteen kilograms and four of those kilograms are muscle, he has not just lost weight. He has accelerated his aging by something like five to seven years in four months.

The mirror lies to him. The scale lies to him. His clothes lie to him.

His grip strength does not lie. His ability to stand up from a low chair without using his hands does not lie. His balance on one foot with his eyes closed does not lie.

Losing 14 kilos sounds great. Losing 4 kilos of muscle at fifty-nine does not.

Why I Am Not Saying Don't Take It

I want to be careful here, because I have seen the other extreme too — the men who refuse any medical help, who treat insulin resistance like a character flaw, who white-knuckle their way through metabolic disease and end up with neuropathy and cardiac events and regret.

If your doctor has prescribed a GLP-1 drug for type 2 diabetes or significant obesity, and you have had a real conversation about the risks and the trade-offs, that is between you and your doctor. I am not in that room. I do not know your A1C. I do not know your family history. I am not your physician.

What I am saying is this: if you are taking it, you cannot take it the way the commercials suggest you take it. You cannot just take it and wait. You cannot eat less of everything and call that a strategy.

You have to protect the muscle. You have to protect the bone. You have to protect the cardiovascular conditioning that does not come from weight loss alone.

And the boring, unglamorous, unpatentable thing that does all three of those at once is walking.

Not running. Not HIIT. Not whatever a forty-year-old fitness influencer is se

What Walking Actually Does That Ozempic Cannot

I want to give you the research, not the inspiration. Inspiration is cheap. Men our age have heard enough of it.

Walking thirty to sixty minutes a day, at a pace where you can talk but not sing, does five things that no medication does:

One. It preserves Type I muscle fibers — the slow-twitch endurance fibers that GLP-1 weight loss tends to spare less than people think. These are the fibers that keep you upright, keep you walking up stairs, keep you carrying groceries at seventy.

Two. It loads your bones. Every step is a small impact, and bones respond to impact by staying dense. Wegovy does not load your bones. Neither does swimming, for that matter. Walking does, and it does it for free.

Three. It improves insulin sensitivity independently of weight loss. This is the one most men miss. You can be at a "healthy" weight on Ozempic and still have terrible glucose control if your muscles are not pulling sugar out of your blood. Walking trains your muscles to do exactly that, and it works the same day you do it.

Four. It lowers cortisol. Men our age who have spent thirty years in corporate jobs — and I am one of them — have nervous systems that are still running on 2003 deadlines. Walking outside, especially in the morning, resets that. No supplement does this as reliably.

Five. It is sustainable. You can do it at fifty-nine. You can do it at seventy-nine. You cannot say that about most exercise programs, and you definitely cannot say it about a medication that costs what these medications cost without insurance.

The medication may or may not be there in ninety days. The walking is the constant.

What I Told Him at the End

I told the schoolteacher this. I am going to tell you the same thing.

If you are on a GLP-1 medication, walk every day. Not five times a week. Every day. Thirty minutes minimum, sixty if you can. Outside if possible. Carry something light if you can — a small backpack, a water bottle in each hand. Make your muscles ask for protein, and then give them protein. Aim for thirty grams at breakfast. I know that sounds like a lot. It is not. It is what your sixty-year-old body needs to hold onto what it has.

If you are not on a GLP-1 medication and you are thinking about asking for one, ask yourself first: have I walked every day for ninety days? Have I eaten thirty grams of protein at breakfast for ninety days? Have I lifted something heavy twice a week for ninety days?

If the answer is no, you do not yet know whether you need the medication. You have not run the experiment.

The medication will still be there in ninety days. The muscle you have right now will not, if you do nothing.

I am not telling you this because I sell supplements. I sell supplements, and I will tell you honestly that the supplement most men our age actually need is creatine and a decent protein powder, and that combined costs less than one month of Wegovy without insurance. I am telling you this because I am the same age as you, and I have watched too many friends choose the fast answer and pay for it slowly.

The injection promises speed. The walking promises something the injection cannot — durability.

You get to choose which one you want to be at seventy-five.

Choco Papa, walking. See you in the next inning.

---

References

1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989. (Foundational STEP trial showing weight loss composition.)
2. Conte C et al. Is weight loss-induced muscle mass loss clinically relevant? J Clin Endocrinol Metab. 2024;109(5):1466-1474.
3. Mayo Clinic. GLP-1 agonists and lean mass: what clinicians should know. 2024 review.
4. Cleveland Clinic. Sarcopenia and aging: prevention strategies for adults over 50. 2025.
5. Cruz-Jentoft AJ et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16-31.
6. Tieland M et al. Skeletal muscle performance and ageing. J Cachexia Sarcopenia Muscle. 2018;9:3-19.
7. Colberg SR et al. Physical Activity/Exercise and Diabetes: ADA Position Statement. Diabetes Care. 2016;39:2065-2079.
8. Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009;12:86-90.

This article reflects the personal experience and reading of the author, who is not a licensed physician. It is not medical advice. Decisions about prescription medications should be made with your doctor.

lling on Instagram this week.

Walking. Daily. For the rest of your life.